Bank Of Montreal Renovo Rx, Inc. Transaction History

Bank Of Montreal

$214 Billion
Q3 2024

A detailed history of Bank Of Montreal transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 975,000 shares of RNXT stock, worth $1.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

975,000

Holding current value

$1.22 Million

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 13, 2024	BUY	$0.96 - $1.29 $936,000 - $1.26 Million	975,000 New	975,000 $1.03 Million
Q1 2023 Jun 13, 2024	BUY	$2.51 - $5.25 $2.45 Million - $5.12 Million	975,000 New	975,000 $3.39 Million

Others Institutions Holding RNXT

# of Institutions

Shares Held

2.87M

Call Options Held

Put Options Held

Bank Of The West

975K
Shares

$1.22 Million
0.27% of portfolio
Adar1 Capital Management, LLC Austin, TX

315K
Shares

$393,990
0.05% of portfolio
Geode Capital Management, LLC Boston, MA

233K
Shares

$291,171
0.0% of portfolio
Nixon Peabody Trust CO Boston, MA

97.2K
Shares

$121,456
0.01% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

82.4K
Shares

$102,941
0.0% of portfolio

View Full List

About RenovoRx, Inc.

Ticker RNXT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,066,860
Market Cap $11.3M
Description
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...

More about RNXT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account